News > Press Releases

Press Releases

Jefferson Scientists Discover Mechanism Tying Obesity to Alzheimer's Disease

Jefferson Biologist Coaxing Human Embryonic Stem Cells to Make Dopamine with Simpler, Faster Method

Free Community Forum on What We Know and Don't Know About Alzheimer's Disease Features Experts from Jefferson's Farber Institute for Neurosciences

Pennsylvania Department of Health Awards Jefferson $3.5 Million from Tobacco Settlement Funds to Establish a New Center of Excellence on Neurodegenerative Diseases

Jefferson Scientists Uncover New Evidence to Help Explain Statins' Effects in Alzheimer's Disease

Jefferson's Farber Institute for Neurosciences to Host Open House for New Ph.D. Program in Neuroscience

Thomas Jefferson University Hospital Celebrates 126th Anniversary

Vickie and Jack Farber to Be Honored at Thomas Jefferson University Hospital's 126th Anniversary Celebration

Three Honored as Thomas Jefferson University Hospital Celebrates 126 Years of Service

Jefferson Neuroscientists Studying New Type of Alzheimer's Drug Aimed at Halting Disease Progression
(Published 11-2-2004) Neuroscientists at the Farber Institute for Neurosciences at Thomas Jefferson University in Philadelphia will begin a clinical trial testing a new type of drug that attacks amyloid, the protein substance that accumulates in the brains of Alzheimer's disease patients.

Jefferson Hospital for Neuroscience Among Leaders in Both Clinical Expertise and Basic Science Research
(Published 10-26-2004)

Jefferson Scientists Uncover New Evidence to Help Explain Statins' Effects in Alzheimer's Disease
(Published 10-25-2004) Scientists at Jefferson Medical College and the Farber Institute for Neurosciences at Thomas Jefferson University in Philadelphia have taken another step in understanding the potential effects of anti-cholesterol drugs on Alzheimer's disease.

Jefferson Scientists Find New Way to Convert Adult Human Stem Cells to Longer-Lasting Dopamine Neurons
(Published 10-25-2004) Researchers at Jefferson Medical College have found a new way to coax bone marrow stem cells into becoming dopamine-producing neurons.

Vickie and Jack Farber to Be Honored at Thomas Jefferson University Hospital's 126th Anniversary Celebration
(Published 10-20-2004) As part of its 126th anniversary celebration, Vickie and Jack Farber will be honored at a Gala for Thomas Jefferson University Hospital on Monday evening, Nov. 8, at the Philadelphia Marriott Hotel.

Thomas Jefferson University Hospital Celebrates 126th Anniversary
(Published 10-4-2004) Gala Event to Feature Awards of Achievement and Merit

Going Where Many Have Not Yet Gone-- Experts on Alzheimer's disease, which Struck Pres. Reagan and Star Trek's "Scotty," Will De-Mystify Illness and Discuss New Treatments on the Horizon at July 23 Public Forum
(Published 7-12-2004) The forum comes at the close of the 9th International Conference on Alzheimer's Disease and Related Disorders (ICAD) being held in Philadelphia.

Jefferson Alzheimer's Vaccine Shows Promise in Animal Model
(Published 3-5-2004) A new vaccine for Alzheimer's disease created by researchers at the Farber Institute for Neurosciences at Thomas Jefferson University in Philadelphia has shown promise in initial testing in primates.

Jefferson Neuroscientists to Test New Stroke Prevention Drug
(Published 5-13-2003) Neuroscientists at the Farber Institute for Neurosciences at Thomas Jefferson University in Philadelphia will help conduct the first clinical trial looking at the potential usefulness of a drug to prevent patients who have already suffered a hemorrhagic, or bleeding stroke, from having a second one.

Pres. Reagan's Daughter and Actor David Hyde Pierce Will Be Featured Speakers at Dedication of Jefferson's Farber Institute for Neurosciences
(Published 4-23-2003) Patti Davis and David Hyde Pierce public advocates for Alzheimer's disease research, will be special guests at the Monday, May 19, dedication luncheon and tour of the new labs at Farber Institute at the Jefferson Hospital for Neuroscience.

Neuropsychiatry Specialist Named Director of Clinical Alzheimer's Research Program at Jefferson's Farber Institute for Neurosciences
(Published 3-25-2003) Barry W. Rovner, M.D., director of the Division of Geriatric Psychiatry and professor of Psychiatry and Human Behavior, Jefferson Medical College of Thomas Jefferson University, has been named director of Clinical Alzheimer's Research at the Farber Institute for Neurosciences of Thomas Jefferson University.

Lorraine Iacovitti, Ph.D., Named Associate Director of Jefferson's Farber Institute for Neurosciences
(Published 7-22-2002) Developmental biologist Lorraine Iacovitti, Ph.D., professor of neurology at Jefferson Medical College of Thomas Jefferson University in Philadelphia, has been named associate director of Jefferson's Farber Institute for Neurosciences.

Alzheimer's Disease Specialist Begins Work as First Director of New Farber Institute for Neuroscience at Thomas Jefferson University
(Published 2-4-2002) Alzheimer's disease specialist Samuel E. Gandy III, M.D., Ph.D., has begun his duties as the first director of the Farber Institute for Neurosciences at Thomas Jefferson University, Philadelphia.

Farber Family Foundation Gives $10 Million to Jefferson to Establish Farber Institute for Neurosciences
(Published 12-5-2001) The Farber Family Foundation, Inc. has given $10 million to Thomas Jefferson University in Philadelphia to establish a new neurosciences research institute, one of the largest gifts the university has ever received.

Jefferson Researchers Have Early Evidence of Bone Marrow Stem Cells Able to Become Brain Cells
(Published 11-11-2001) Using a potion of growth factors and other nutrients, scientists at Jefferson Medical College have shown in the laboratory they are able to convert adult human bone marrow stem cells into adult brain cells.

Please click here for a high resolution JPG of Dr. Gandy
To download this image, you can right click on this link and select "Save Target As..." or you can click on the link and then right click on the image and select "Save Picture As...". Make sure to note where you have saved the photo.